Skip to main content

Table 2 Use of healthcare services (incidence rate ratios, IRR). Results of standard or zero-inflated negative binomial regression models across immigrant groups

From: Global healthcare use by immigrants in Spain according to morbidity burden, area of origin, and length of stay

 

Use of Primary Care (visits to doctor)

Use of Specialised Care

Use of Hospital Care (total admissions)

Use of Hospital Care (unplanned admissions)

Use of Emergency Care

Pharmacy Use

IRRa

IRRb

IRRa

IRRb

IRRa

IRRb

IRRa

IRRb

IRRa

IRRb

IRRa

IRRb

Length of stay in Spain < 5 years

Children

Nationals (ref)

1.00

          

Immigrants

0.79

0.93

0.59

0.70

1.02

1.30

0.83*

1.03

0.76

0.92*

0.66

0.71

Africa

0.80

0.95

0.57

0.67

1.45

1.81

0.95

1.15

0.59

0.69

0.75

0.87

Asia

0.59

0.83

0.39

0.55

0.32*

0.51

0.43*

0.69

1.03

1.50

0.35

0.41

Eastern Europe

0.84

0.96

0.55

0.65

0.81*

1.01

0.81

0.99

0.89*

1.07

0.66

0.70

Latin America

0.78

0.92

0.75

0.88*

1.01

1.24

0.77

0.96

0.78

0.92

0.65

0.64

Western Europe & North America

0.52

0.69

0.45

0.57

0.54

0.8

0.68

1.0

0.60

0.79

0.41

0.40

Adults

Nationals (ref)

1.00

          

Immigrants

0.68

0.88

0.60

0.71

0.78

0.91

0.95

1.03

0.87

1.05*

0.37

0.41

Africa

0.88

1.06

0.68

0.72

1.02

1.05

1.42

1.36

0.96

1.07*

0.40

0.45

Asia

0.46

0.75

0.52

0.65

0.74*

0.88

1.1

1.2

0.82*

1.12

0.26

0.33

Eastern Europe

0.57

0.80

0.52

0.65

0.67

0.83

0.79

0.89*

0.77

0.98

0.34

0.37

Latin America

0.76

0.88

0.84

0.99

0.84

0.96

0.88*

0.97

1.02

1.19

0.40

0.45

Western Europe & North America

0.44

0.69

0.39

0.49

0.40

0.54

0.47

0.58*

0.47

0.62

0.38

0.36

Length of stay in Spain ≥ 5 years

Children

Nationals (ref)

1.00

          

Immigrants

0.77

0.90

0.61

0.69

0.79*

0.93

0.71*

0.84

0.69

0.79

0.55

0.60

Africa

0.80

0.90

0.56

0.62

0.53

0.58

0.62*

0.7

0.54

0.60

0.58

0.58

Asia

0.63

0.84

0.56

0.72*

0.44

0.65

0.46

0.67

0.95

1.29

0.55

0.72*

Eastern Europe

0.78

0.90

0.59

0.65

0.88

1.04

0.74

0.89

0.80

0.9

0.60

0.63

Latin America

0.78

0.92

0.73

0.86*

1.2

1.53*

0.87

1.02

0.71

0.82*

0.42

0.53

Western Europe & North America

0.61

0.78

0.61

0.73*

0.68

0.9

0.8

1.05

0.69*

0.86

0.52

0.83*

Adults

Nationals (ref)

1.00

          

Immigrants

0.88

0.95

0.71

0.74

0.78

0.83

0.91

0.94*

1.07

1.16

0.53

0.54

Africa

1.04

1.10

0.71

0.70

0.74

0.76

0.97

0.98

1.06*

1.11

0.54

0.56

Asia

0.67

0.84

0.64

0.74

0.71*

0.81

0.92

1.02

1.02

1.24

0.41

0.47

Eastern Europe

0.80

0.90

0.72

0.76

0.76

0.83

0.87*

0.93*

1.03*

1.14

0.53

0.55

Latin America

0.91

0.93

0.90

0.92

0.86

0.89

0.94

0.96

1.25

1.32

0.49

0.50

Western Europe & North America

0.68

0.79

0.64

0.66

0.74

0.81*

0.78*

0.82*

0.65

0.73

0.73

0.71

  1. aAdjusted by age and sex bAdjusted by age, sex and morbidity burden
  2. In those cases where the Vuong test was statistically non-significant showing large negative values, standard negative binomial models were employed, *p < 0.05, p < 0.001